Cleavage of urokinase receptor regulates its interaction with integrins in thyroid cells

被引:23
作者
Montuori, N
Rossi, G
Ragno, P
机构
[1] CNR, CEOS, Ctr Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy
[2] Univ Naples, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy
关键词
urokinase; urokinase receptor; beta-integrin; thyroid;
D O I
10.1016/S0014-5793(99)01314-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The urokinase-type plasminogen activator uPA-R can regulate integrin functions by associating with several types of beta-subunit, We have recently shown that normal thyroid TAD-2 cells express both a native and a cleaved form of uPA-R which lacks the binding domain for uPA, We found this cleaved form to be present in reduced amounts in papillary and follicular thyroid carcinoma cells and completely absent in cells derived from an anaplastic thyroid carcinoma (ARO). We now report that in normal thyroid cells the intact form of uPA-R strongly associates with beta-1 integrins,,whereas its cleaved form does not. uPA-R expressed by ARO cells shows a stronger resistance to the cleavage mediated by uPA, plasmin and chymotrypsin than does uPA-R expressed by normal thyroid cells, This resistance to cleavage correlates with the higher level of glycosylation of uPA-R of ARO cells as compared to that of cleavable uPA-R of normal thyroid cells. These results suggest that uPA-R cleavage, which occurs in several cell types, represents a mechanism regulating the interactions of uPA-R with integrins and, possibly, the subsequent integrin-mediated cell adhesion. Moreover we hypothesize that glycosylation regulates uPA-R cleavage and, indirectly, its interaction with integrins. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 23 条
[1]  
ALBELDA SM, 1993, LAB INVEST, V68, P4
[2]  
BEHRENDT N, 1990, J BIOL CHEM, V265, P6453
[3]  
Blasi F, 1999, BIOCHIM BIOPHYS ACTA, V1423, P35
[4]   Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration [J].
Chapman, HA .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (05) :714-724
[5]   HLA-DR GENE-EXPRESSION IN A PROLIFERATING HUMAN THYROID CELL CLONE (12S) [J].
CONE, RD ;
PLATZER, M ;
PICCININI, LA ;
JARAMILLO, M ;
DAVIES, TF .
ENDOCRINOLOGY, 1988, 123 (04) :2067-2074
[6]   THE UROKINASE RECEPTOR - PROTEIN-STRUCTURE AND ROLE IN PLASMINOGEN ACTIVATION AND CANCER INVASION [J].
DANO, K ;
BEHRENDT, N ;
BRUNNER, N ;
ELLIS, V ;
PLOUG, M ;
PYKE, C .
FIBRINOLYSIS, 1994, 8 :189-203
[7]  
ELLIS V, 1989, J BIOL CHEM, V264, P2185
[8]   CHARACTERIZATION OF A HUMAN FOLLICULAR THYROID-CARCINOMA CELL-LINE (UCLA-RO 82 W-1) [J].
ESTOUR, B ;
VANHERLE, AJ ;
JUILLARD, GJF ;
TOTANES, TL ;
SPARKES, RS ;
GIULIANO, AE ;
KLANDORF, H .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1989, 57 (03) :167-174
[9]   A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity [J].
Fazioli, F ;
Resnati, M ;
Sidenius, N ;
Higashimoto, Y ;
Appella, E ;
Blasi, F .
EMBO JOURNAL, 1997, 16 (24) :7279-7286
[10]   The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction [J].
Hoyer-Hansen, G ;
Behrendt, N ;
Ploug, M ;
Dano, K ;
Preissner, KT .
FEBS LETTERS, 1997, 420 (01) :79-85